17 articles
Engineered "hypoimmune" stem cells could restore vision lost to macular degeneration without lifelong immune-suppressing drugs, backed by a $4.2 million.
AI spots macular degeneration with 90% accuracy using retinal photos taken right in your primary care office, no eye dilation required.
Medicare Advantage plans steer patients toward cheaper eye injections, with bevacizumab used 13 points more often, limiting access to newer retinal.
The FDA has approved LYTENAVA, the first eye-specific bevacizumab for wet age-related macular degeneration, offering patients a validated new option to.
Blue light-filtering cataract lenses offer no measurable advantage over standard UV lenses, a three-year study of 127 eyes confirms.
Anti-inflammatory drugs may delay myopia onset by seven years, a University of Oklahoma study finds, offering hope for preventing serious vision loss in.
Metformin eye drops may soon treat age-related macular degeneration, with a new USPTO patent and first-in-human trials now in planning.
Developing nations are transforming eye care with AI and community workers, yet workforce shortages and less than 0.2% budget funding leave millions.
Retinal detachment surgery improves vision, but recovery plateaus at six months, leaving patients with significantly lower quality of life than healthy.
A gene-agnostic retinal degeneration therapy is restoring up to 6 lines of vision in patients, with gains lasting 3 years regardless of genetic mutation.
A new eyeglass lens called Stellest slows myopia progression in kids by 71%, outperforming drops and contacts with no side effects.
Most adults taking eye health supplements don't understand how diet affects vision, yet fewer than 1 in 10 report good nutritional knowledge, a new study.
Scientists identify five blood compounds that could prevent high myopia and vision loss, with glutamine and tyrosine showing 24-28% risk reduction.
The AAO has embedded eye care guidelines into OpenEvidence, an AI platform used by over 65% of U.S. doctors, giving ophthalmologists free point-of-care.
Vision begins improving within days after cataract surgery, but complete clarity takes several weeks as your eye adjusts to the new lens.
Serious eye diseases like glaucoma and diabetic retinopathy develop without symptoms, making regular eye exams critical for preventing vision loss.
IZERVAY eye drug reduces risk of losing driving ability from geographic atrophy by 41%, offering hope for millions with this progressive vision disease.
